Mutual Funds
AMC
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

Sectoral / Thematic

Invest Now

NAV
14.03(-0.41%)
Fund Size (CR)
₹423.51
Expense Ratio
2.25
Scheme Type
Active Fund
Value Research

Min. investment
₹500
Minimum Additional Investment
₹500
Minimum SIP Investment
₹100
Minimum Withdrawal
₹500
Exit Load
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment
1%
Return Since Launch
23.44%

Absolute Return: 4.10%

Annualized Return: 0%

Basic Details

Scheme Manager

Ramesh Mantri

Bench Mark

BSE Healthcare TRI

Type

OPEN

Lumpsum Returns

Period Invested For	₹10,000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	8 September 2025	10076.13	0.76%	-	1.29%	695/916
1 Month	14 August 2025	10007.13	0.07%	-	2.88%	621/908
3 Month	13 June 2025	10467.02	4.67%	-	3.27%	192/876
6 Month	13 March 2025	11583.55	15.84%	-	17.29%	415/856
1 Year	13 September 2024	10768.29	7.68%	7.68%	-1.28%	69/737
3 Year	-	-	0%	-	18.75%	-/-
5 Year	-	-	0%	-	22.71%	-/-
Since Inception	6 February 2024	14030.00	40.30%	23.44%	13.80%	73/916

Note: Lumpsum Returns since Inception Date.

SIP Returns

Period Invested For	₹10,000 Invested on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	1 October 2024	1,20,000	128636.73	7.20%	7.20%
3 Year	-	-	-	-	-
5 Year	-	-	-	-	-
10 Year	-	-	-	-	-

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

Investment type
Scheme based

SIP
Lumpsum

Monthly Investment (₹)

Expected Returns Rate (%)

Time Period (in Years)

Start your SIP now

Invested Amount
₹25,000
Estimated Returns
₹19,059

76%

Returns

Future value of your investment

₹44,059

Risk Ratios

5.04%

Standard Deviation

0.83%

Beta

0.92%

Sharpe Ratio

0.03%

Treynor's Ratio

14.71%

Jension's Alpha

Asset Allocation

Sector Allocation

Top 10 stock holding in portfolio

Stock Invested in	% of Total Holdings	Quantity	Value (Cr)	Asset Type	Segment
Max Healthcare	6.99%	256451	29.60	Equity	Healthcare
J B Chemicals &	6.80%	167021	28.80	Equity	Pharmaceuticals
Fortis Health.	6.27%	291434	26.56	Equity	Healthcare
Sun Pharma.Inds.	6.09%	161771	25.79	Equity	Pharmaceuticals
Cipla	4.92%	131223	20.86	Equity	Pharmaceuticals
Laurus Labs	4.21%	207928	17.82	Equity	Pharmaceuticals
Krishna Institu.	3.81%	222660	16.12	Equity	Healthcare
Apollo Hospitals	3.27%	18217	13.86	Equity	Healthcare
Vijaya Diagnost.	2.61%	109682	11.05	Equity	Healthcare
Neuland Labs.	2.53%	7963	10.71	Equity	Pharmaceuticals

Peer Comparison

Scheme Name	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Taiwan Equity Fund - Direct (G)	389.09	9.08%	28.31%	50.57%	47.77%	33.03%
Nippon India Taiwan Equity Fund - Direct (IDCW)	389.09	9.08%	28.31%	50.57%	47.77%	33.03%
Aditya Birla SL International Equity Fund - Direct (G)	249.75	2.95%	11.02%	19.06%	28.03%	17.07%
Aditya Birla SL International Equity Fund - Direct (IDCW)	249.75	2.95%	11.02%	19.06%	28.03%	17.07%
Nippon India Japan Equity Fund - Direct (G)	283.56	3.22%	10.49%	15.86%	19.19%	18.55%

List of Schemes under WhiteOak Capital Mutual Fund

Fund Name	Category	Risk	1Y Returns	Ratings	Fund Size (Cr)
WhiteOak Capital ESG Best-In-Class Strategy Fund	Equity	Very High	0%	0	₹67.01
WhiteOak Capital Digital Bharat Fund	Equity	Very High	0%	0	₹359.56
WhiteOak Capital Equity Savings Fund	Hybrid	Moderately High	0%	0	₹102.24
WhiteOak Capital ELSS Tax Saver Fund	Equity	Very High	7.24%	0	₹405.80
WhiteOak Capital Arbitrage Fund	Hybrid	Low	0%	0	₹552.90
WhiteOak Capital Flexi Cap Fund	Equity	Very High	5.3%	0	₹5,446.05
WhiteOak Capital Pharma and Healthcare Fund	Equity	Very High	22.09%	0	₹364.10
WhiteOak Capital Large Cap Fund	Equity	Very High	3.92%	0	₹981.71
WhiteOak Capital Special Opportunities Fund	Equity	Very High	11.59%	0	₹1,041.66
WhiteOak Capital Balanced Advantage Fund	Hybrid	Very High	8.23%	0	₹1,654.01
WhiteOak Capital Balanced Hybrid Fund	Hybrid	High	6.16%	0	₹195.15
WhiteOak Capital Quality Equity Fund	Equity	Very High	0%	0	₹543.09
WhiteOak Capital Banking & Financial Services Fund	Equity	Very High	12.86%	0	₹448.02
WhiteOak Capital Large & Mid Cap Fund	Equity	Very High	4.65%	0	₹1,775.78
WhiteOak Capital Mid Cap Fund	Equity	Very High	5.79%	0	₹3,454.23
WhiteOak Capital Multi Asset Allocation Fund	Hybrid	Very High	16.13%	0	₹2,585.54
WhiteOak Capital Liquid Fund	Debt	Low	7.03%	2	₹595.02
WhiteOak Capital Ultra Short Duration Fund	Debt	Low	7.56%	3	₹517.87
WhiteOak Capital Multi Cap Fund	Equity	Very High	7.51%	0	₹2,065.13

News

WhiteOak Capital Mutual Fund announces change in Key Personnel
WhiteOak Capital Mutual Fund has announced that Mr. Siddhartha Chaturvedi has been appointed as a Chief Information Security Officer on the Board of the Trustee Company with effect from July 01, 2025.
Details of Mr. Siddhartha Chaturvedi
Age: 43
Designation: Chief Information Security Officer
Qualification : B.Tech. ' Information Technology, CISA, CEH, CND, CCNA (S & R), CCNA (Security), ITIL Foundation, RBI Certified Cyber Security Professional (Under AVTU) Mission, ISEA Certified Cyber Hygiene Practitioner from MeITY
Experience: 16
Powered by Capital Market - Live News

WhiteOak Capital Mutual Fund announces change in fund manager under its schemes

WhiteOak Capital Mutual Fund has announced change in fund manager under the following schemes, with effect from 20 May 2025.

Change in Fund Manager:

Name of the Scheme	Existing Fund Manager(s)	Revised Fund Manager(s)
WhiteOak Capital Special Opportunities Fund	' Mr. Dheeresh Pathak (Equity) ' Ms. Trupti Agrawal (Equity) ' Mr. Piyush Baranwal (Debt) ' Mr. Ashish Agrawal (Arbitrage)	' Mr. Dheeresh Pathak (Equity) ' Ms. Trupti Agrawal (Equity) ' Mr. Piyush Baranwal (Debt) ' Mr. Ashish Agrawal (Arbitrage) ' Mr. Ramesh Mantri (Equity) (Addition)
WhiteOak Capital Pharma and Healthcare Fund	' Mr. Ramesh Mantri (Equity) ' Mr. Dheeresh Pathak (Equity) ' Mr. Piyush Baranwal (Debt) ' Mr. Ashish Agrawal (Arbitrage)	' Mr. Ramesh Mantri (Equity) ' Mr. Dheeresh Pathak (Equity) ' Mr. Piyush Baranwal (Debt) ' Mr. Ashish Agrawal (Arbitrage) ' Ms. Trupti Agrawal (Equity) (Addition)
WhiteOak Capital Multi Asset Allocation Fund	' Mr. Ramesh Mantri (Equity) ' Mr. Dheeresh Pathak (Equity) ' Mr. Piyush Baranwal (Debt) ' Mr. Ashish Agrawal (Arbitrage)	' Mr. Ramesh Mantri (Equity) ' Mr. Dheeresh Pathak (Equity) ' Mr. Piyush Baranwal (Debt) ' Mr. Ashish Agrawal (Arbitrage) ' Ms. Trupti Agrawal (Equity) (Addition)

Powered by Capital Market - Live News

Fund House Details & Investment Objective

Date of Incorporation

16 January 2024

Total AUM (Cr)

₹423.51

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹423.51 (Cr), as of 15 September 2025, WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 23.44% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is ₹14.03, as on 15 September 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Reg (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.

Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment. The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 89.71% in Equity, 10.01% in Debt and 0.28% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 58.84% in Pharmaceuticals & Biotech, 29.35% in Healthcare Services, 5.33% in Debt, 2.93% in Cash & Others, 1.58% in Chemicals & Petrochemical